Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:915 (15 April), doi:10.1136/bmj.332.7546.915-a
| The first 150 words of the full text of this article appear below. |
EDITORHooper et al's conclusions that omega 3 fats have no effect on total mortality, combined cardiovascular events, or cancer are somewhat misleading.1
Firstly, their null findings could be partly explained by the use of the composite end points. They ignore strong biological evidence for the potentially disease specific effects of omega 3 fat. The underlying hypotheses for this study are not clearly stated for the main analyses. Systematic reviews have been published of the effect on mortality from coronary heart disease of long chain omega 3 polyunsaturated fatty acids in randomised controlled trials and fish in prospective cohort studies.2 3
Secondly, the authors focus primarily on the summary estimates from heterogeneous studies.
Thirdly, Hooper et al exclude 108 potential cohorts that have no omega 3 assessment. Dietary intake of long chain omega 3 fatty acids assessed by dietary instruments is more likely to be a surrogate marker of fish
Ka He, assistant professor
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 North Lake Shore Drive, Suite 1102, Chicago, IL 60611, USA kahe@northwestern.edu
Yiqing Song, instructor
Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215, USA